Rational Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Rational Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $77,518 - $88,170	100 New	100 $87,000
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $1.4 Million - $1.7 Million	2,060 New	2,060 $1.69 Million
Q1 2021 May 10, 2021	SELL	$446.73 - $548.2 $804,114 - $986,760	-1,800 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$478.3 - $607.98 $850,417 - $1.08 Million	1,778 Added 8081.82%	1,800 $870,000
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $3,268 - $3,949	-6 Reduced 21.43%	22 $12,000
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $13,812 - $18,029	28 New	28 $17,000
Q1 2020 May 12, 2020	SELL	$336.18 - $494.43 $8,068 - $11,866	-24 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$274.13 - $376.51 $64,694 - $88,856	-236 Reduced 90.77%	24 $9,000
Q3 2019 Nov 06, 2019	BUY	$273.46 - $318.39 $49,222 - $57,310	180 Added 225.0%	260 $72,000
Q2 2019 Aug 08, 2019	SELL	$299.6 - $414.82 $1.5 Million - $2.08 Million	-5,017 Reduced 98.43%	80 $25,000
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $1.89 Million - $2.23 Million	5,073 Added 21137.5%	5,097 $2.09 Million
Q4 2018 Feb 07, 2019	BUY	$335.82 - $403.04 $7,388 - $8,866	22 Added 1100.0%	24 $9,000
Q3 2018 Nov 08, 2018	SELL	$351.14 - $408.51 $351 - $408	-1 Reduced 33.33%	2 $1,000
Q2 2018 Aug 07, 2018	BUY	$284.6 - $344.99 $853 - $1,034	3 New	3 $1,000

1,488

85.7M

1.53M

1.44M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $77.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Rational Advisors LLC with notifications on news.